Qualcomm Incorporated (NASDAQ: QCOM) today announced the appointment of Jeffrey W. Henderson to its Board of Directors. Henderson brings 30 years of financial and operational management experience to his position as an independent director, including 10 years as Chief Financial Officer of Cardinal Health, a Fortune 30 healthcare company.
"We are happy to welcome Jeff to Qualcomm’s Board of Directors,” said Dr. Paul E. Jacobs, chairman of the board of Qualcomm Incorporated. "Over his career he has demonstrated a strong commitment to building sustainable value for stockholders. Jeff brings significant, complementary leadership skills to our board, including experience in strategy, finance, international and commercial operations and will provide a valuable resource to our directors and senior executive team.”
During his tenure in senior operational and financial management positions, Henderson has successfully executed on strategic growth and transformation strategies, including strategies to adapt and grow in the fast-changing global healthcare landscape and expand into new, complementary business areas.
Henderson has been an Advisory Director to Berkshire Partners LLC, a private equity firm, since September 2015. He served as Chief Financial Officer of Cardinal Health Inc., a healthcare services company, from May 2005 to November 2014. Prior to joining Cardinal Health, Henderson held multiple positions at Eli Lilly and General Motors, including serving as President and General Manager of Eli Lilly Canada, Controller and Treasurer of Eli Lilly Inc. and in management positions with General Motors in Great Britain, Singapore, Canada and the U.S.
Henderson has been a Director of Halozyme Therapeutics, Inc. since August 2015 and a Director of FibroGen, Inc. since August 2015. He holds a B.S. degree in electrical engineering from Kettering University and an M.B.A. degree from Harvard Business School.
About Qualcomm Incorporated
Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm’s licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm’s engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages